Vita Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 12, 2022
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $31,000,000
Company Info
- Traction
- The company is currently working with numerous partners, including PanCella, Wyss Institute, and Johns Hopkins University, to advance their clinical programs.
- Organizations Involved
- PanCella, Wyss Institute, Johns Hopkins University
- Founders
- Douglas Falk
- Company Description
- Vita Therapeutics is a cell engineering company that develops life-transformative treatments.
- Market
- Cellular therapeutics for neuromuscular diseases and cancers
- Location
- Baltimore, MD, USA
- Coinvestors
- Cambrian Biopharma, Cedars-Sinai Medical Center, Riptide Ventures, Solve FSHD, TEDCO